Indications, modifications and technique of ECMO with or without NO-therapy.
Pappert
D
D
Klinik für Anaesthesiologie und operative Intensivmedizin, Virchow-Klinikum, Humboldt Universität zu Berlin. dpappert@ukrv.de
Falke
K J
KJ
D000280:Administration, Inhalation; D000925:Anticoagulants / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation / Q000295:instrumentation / Q000379:methods; D006801:Humans; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010107:Oxygenators, Membrane; D011175:Positive-Pressure Respiration; D011652:Pulmonary Circulation / Q000187:drug effects; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D012128:Respiratory Distress Syndrome / Q000188:drug therapy / Q000628:therapy; D012138:Respiratory Therapy; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016278:Ventricular Function, Right / Q000187:drug effects
D000925:Anticoagulants; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D009569:Nitric Oxide; D011464:Epoprostenol; D010100:Oxygen